BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li N, Zhou G, Zheng Y, Lv D, Zhu X, Wei P, Zheng M, Liu S, Zhou E, Sun W, Zhang L. Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis. PLoS One 2022;17:e0261986. [PMID: 35020750 DOI: 10.1371/journal.pone.0261986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shibata R, Taguchi K, Kaida Y, Fukami K. Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus. Clin Exp Nephrol. [DOI: 10.1007/s10157-022-02277-y] [Reference Citation Analysis]
2 Klonoff DC, Xu NY, Nguyen KT, Kerr D, Mehta C, Umpierrez GE, Brooks GA. Trimetazidine Blocks Lipid Oxidation-Should it be Repurposed for Prevention and Treatment of Diabetic Ketoacidosis? J Diabetes Sci Technol 2022;:19322968221100196. [PMID: 35652624 DOI: 10.1177/19322968221100196] [Reference Citation Analysis]